articles

Hurricanes Florence and Michael in the U.S. and Super Typhoon Mangkhut in the Philippines have shown the widespread and harmful impact of weather extremes on both ecosystems and built communities, with flash floods causing more deaths, as well as property and agriculture losses than from any other severe weather-related hazards. These losses have been increasing over the past 50 years and have exceeded $30 billion per year in the past decade. Globally, almost one billion people now live in floodplains, raising their exposure to river flooding from extreme weather events and underscoring the urgency in understanding and predicting these events. 

People with high blood pressure taking medication for their condition are more likely to benefit from the therapy if they have good oral health, according to new research in the American Heart Association’s journal Hypertension.

It’s called ArcCI (or Arctic CyberInfrastructure) and promises to combine the thousands of images that have been taken along the years of the Arctic Ocean into one global database that will help scientists and the world see the physical changes occurring in the region including ice loss. The hope is that this web-based repository will allow researchers to spend more time analyzing information rather than just collecting and processing data.

Most parents know that the diet and exercise habits of a pregnant woman impacts the health of her baby, but little is known about how a father’s health choices are passed to his children. A new study by researchers at The Ohio State University Wexner Medical Center finds that lifestyle practices of fathers prior to conception may have a major impact on the lifelong health of their children.

Treatment with the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib achieves a clinically meaningful improvement in overall survival in patients with hormone receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer that has relapsed or progressed on hormonal therapy, according to the final analysis of overall survival results from the PALOMA-3 study reported at ESMO 2018 (1).